Liraglutide

Liraglutide is a once-daily injectable medication used for the treatment of type 2 diabetes and obesity. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the action of a hormone called glucagon-like peptide-1. This hormone helps regulate blood sugar levels and promotes a feeling of fullness, aiding in weight management.
In patients with type 2 diabetes, Liraglutide improves blood sugar control by increasing insulin production, decreasing glucagon secretion, and slowing down the digestion of food. This results in reduced blood sugar levels after meals and improved overall glycemic control. Liraglutide is often used in combination with other diabetes medications, such as metformin or insulin, to achieve better blood sugar management.
For patients with obesity, Liraglutide aids in weight loss by promoting a sense of fullness and reducing food intake. It also helps in reducing body fat and improving cardiovascular risk factors, such as blood pressure and cholesterol levels. Liraglutide is typically used as an adjunct to a reduced-calorie diet and increased physical activity for weight management.
Liraglutide is available in different formulations, including a pre-filled pen and a pre-filled injection cartridge, making it easy for patients to administer the medication at home. It is important to follow the prescribed dosing regimen and monitor blood sugar levels regularly while using Liraglutide. Patients should also report any side effects or concerns to their healthcare provider.